Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants

  1. Bove, R.
  2. Hellwig, K.
  3. Pasquarelli, N.
  4. Borriello, F.
  5. Dobson, R.
  6. Oreja-Guevara, C.
  7. Lin, C.-J.
  8. Zecevic, D.
  9. Craveiro, L.
  10. McElrath, T.
  11. Vukusic, S.
Aldizkaria:
Multiple Sclerosis and Related Disorders

ISSN: 2211-0356,  2211-0348

Argitalpen urtea: 2022

Alea: 64

Mota: Artikulua

DOI: 10.1016/J.MSARD.2022.103963 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus